TESORIERE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.056
EU - Europa 2.414
AS - Asia 1.650
SA - Sud America 252
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.438
Nazione #
US - Stati Uniti d'America 4.020
IT - Italia 656
CN - Cina 633
SG - Singapore 588
FI - Finlandia 477
UA - Ucraina 362
BR - Brasile 209
IE - Irlanda 168
HK - Hong Kong 165
RU - Federazione Russa 161
DE - Germania 160
GB - Regno Unito 93
SE - Svezia 78
PL - Polonia 77
VN - Vietnam 62
FR - Francia 40
RO - Romania 37
CI - Costa d'Avorio 25
IR - Iran 23
TR - Turchia 22
IN - India 21
KR - Corea 20
BE - Belgio 19
NL - Olanda 19
BD - Bangladesh 16
ES - Italia 15
AR - Argentina 14
CA - Canada 14
JP - Giappone 14
MX - Messico 14
AT - Austria 13
ZA - Sudafrica 13
PK - Pakistan 10
CH - Svizzera 9
ID - Indonesia 9
IQ - Iraq 9
SA - Arabia Saudita 9
CO - Colombia 8
MY - Malesia 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
KE - Kenya 6
MA - Marocco 6
BG - Bulgaria 5
GR - Grecia 5
KZ - Kazakistan 5
PT - Portogallo 5
CZ - Repubblica Ceca 4
HN - Honduras 4
JO - Giordania 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
DZ - Algeria 3
EU - Europa 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
UY - Uruguay 3
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
MT - Malta 2
PH - Filippine 2
SN - Senegal 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.438
Città #
Ashburn 456
Fairfield 409
Singapore 338
Chandler 318
Woodbridge 272
Houston 267
Wilmington 213
Jacksonville 202
Seattle 169
Hong Kong 164
Ann Arbor 155
Dublin 153
Beijing 135
Palermo 134
Cambridge 119
Medford 103
Nanjing 88
Dallas 87
Des Moines 81
Princeton 63
Zgierz 62
The Dalles 61
New York 54
Los Angeles 52
Tulsa 47
Moscow 46
Dearborn 42
Boardman 35
Changsha 34
Jinan 33
Altamura 30
Hefei 28
Santa Clara 28
Abidjan 25
Lawrence 25
Hebei 24
Shenyang 24
Ho Chi Minh City 23
Nanchang 23
San Diego 23
Buffalo 21
Hanoi 20
Brussels 19
Tianjin 19
Guangzhou 17
Jiaxing 17
São Paulo 17
Milan 16
Verona 16
Council Bluffs 14
Bremen 13
Hangzhou 12
Menlo Park 12
Zhengzhou 12
Düsseldorf 11
London 11
Napoli 11
Tokyo 11
Kraków 10
Ludwigshafen am Rhein 10
Rio de Janeiro 10
Seoul 10
Venice 10
Chicago 9
Rome 9
Atlanta 8
Brooklyn 8
Columbus 8
Frankfurt 8
Saint Petersburg 8
Tehran 8
Amsterdam 7
Izmir 7
Ankara 6
Brasília 6
Denver 6
Johannesburg 6
Lanzhou 6
Monreale 6
Ningbo 6
Redwood City 6
Seongnam 6
Taiyuan 6
Boston 5
Cape Town 5
Dhaka 5
Faisalabad 5
Frankfurt am Main 5
Fuzhou 5
Haikou 5
Kunming 5
Madrid 5
Orem 5
Phoenix 5
San Mateo 5
Taizhou 5
Turku 5
Vienna 5
Washington 5
Amman 4
Totale 5.188
Nome #
THE APOPTOTIC EFFECT INDUCED IN HepG2 CELLS BY INHIBITORS OF HISTONE DEACETYLASES IS CORRELATED WITH ACETYLATION OF p53 AND HISTONES. 379
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis 252
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. 208
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. 207
Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL. 200
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. 199
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 198
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways 195
Retinoblastoma: History of His Identification, Characterization and Treatment 192
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells. 190
Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. 188
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. 177
Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as an useful in vitro model to develop several purposes 172
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 171
The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. 171
Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). 169
Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors. 167
Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. 167
3AB-OS, a new human pluripotent cancer stem cell: properties and expectations for practical applications. 164
Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. 164
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation 160
COINVOLGIMENTO DELLO STRESS DEL RETICOLO E DEL PROCESSO AUTOFAGICO NELL’APOPTOSI INDOTTA DAL CANNABINOIDE SINTETICO WIN IN CELLULE DI EPATOMA UMANO IN COLTURA 155
Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. 152
Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8. 150
Parthenolide induces caspase-independent cell death in osteosarcoma, melanoma and breast cancer cells through the induction of oxidative stress. 148
Composizioni farmaceutiche per il trattamento di tumori epatici 145
Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231 144
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. 141
Parthenolide sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis 138
Histone deacetylase inhibitors in cancer therapy: Biological and clinical implications. 132
WIN55,212-2, a synthetic agonist of cannabinoid receptors, sensitizes tumor cells to TRAIL-induced apoptosis. 128
THE ROLE OF THE EXTRINSIC PATHWAY OF APOPTOSIS IN THE EFFECT INDUCED BY SAHA IN HUMAN HEPATOMA CELLS. 127
THE APOPTOTIC EFFECT EXERTED IN HUMAN HEPATOMA CELLS BY THE INHIBITOR OF HISTONE DEACETYLASE SAHA EITHER ALONE OR IN COMBINATION WITH BORTEZOMIB. 126
The HDAC inhibitor SAHA synergistically stimulates the cytotoxic effect induced by Parthenolide in MDA-MB231 cells 124
The mechanism by which histone deacetylase inhibitors sensitize hepatoma and colon cancer cells to TRAIL-induced apoptosis 120
HISTONE DEACETYLASE INHIBITORS SENSITIZE HEPATOMA CELLS TO TRAIL_INDUCED APOPTOSIS 120
Histone deacetylase inhibitors: Epigenetic drugs acting by pleiotropic apoptotic mechanism in tumor cells and highly potent in combination with other antitumor agents. 114
Synergistic interaction between Parthenolide and TRAIL induces apoptosis in human hepatocarcinoma cells. 112
The cytotoxic effect exerted by parthenolide and DMAPT on breast cancer stem-like cells 112
APOPTOTIC EFFECTS INDUCED BY ANANDAMIDE IN HEPATIC CELLS. 110
The synthetic cannabinoid WIN sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by activating p8/CHOP/DR5 axis. 105
Il partenolide sensibilizza le cellule di epatocarcinoma all'apoptosi indotta da TRAIL 104
SYNERGISTIC APOPTOTIC INTERACTION BETWEEN THE HDAC INHIBITOR SAHA AND THE PROTEASOME INHIBITOR BORTEZOMIB IN HUMAN HEPATOMA CELLS. 103
Janus-Faced role of microRNA let-7d in osteosarcoma 3AB-OS cancer stem cells 103
Degradation of IkBalfa during apoptosis induced by proteasome inhibitors in hepatoma cells. 102
The synergistic effect exerted by the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide on triple negative breast canc er cells 102
Quaderni del Dottorato di Ricerca in Oncobiologia Sperimentale: Tecniche e Procedure di Ricerca 98
JNK AND AP-1 MEDIATE APOPTOSIS INDUCED BY BORTEZOMIB IN HEPATOMA HEPG2 CELLS. 97
The transcription factor CHOP is critical for WIN-mediated DR5 up-regulation in apoptosis induced by WIN/TRAIL co-treatment in hepatoma cells 96
New perspectives in tumor therapy: molecular aspects, 2006 93
The cannabinoid WIN induces DR5 receptor expression in hepatoma cells sensitizing them to TRAIL signal 93
Okadaic acid-Parthenolide combination at subtoxic doses induces potent synergistic apoptotic effects in human retinoblastoma Y79 cells by upregulating PTEN. 93
Proteasome inhibitor Velcade induces apoptosis in hepatoma HepG2 cells stimulating both the extrinsic and the intrinsic apoptotic pathways. 92
Role of the acetylation of p53 and histones in SAHA-induced apoptosis in human hepatoma HepG2 cells. 91
The proteasome inhibitor bortezomib in programmed cell death and cancer therapy 91
Synergistic apoptotic effect in HepG2 cells between bortezomib and hystone deacetylase inhibitors 87
Differentiative pathway induced by 3-aminobenzamide in MG-63 human osteosarcoma cells. 85
Synergistic effect of the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide in triple negative breast cancer cells. 85
Role of PPARγ in apoptosis induced by cannabinoids in hepatoma HepG2 cells. 82
The involvement of the c-Jun/JNK/AP-1 pathway and HSPs in apoptosis induced by the proteasome inhibitor PS-341 (Velcade) in human hepatoma cells. 82
Synergistic effects induced by combinations of the synthetic cannabinoid WIN55,212-2 and the death receptor ligand TRAIL in hepatoma HepG2 cells. 82
THE CANNABINOID AGONIST WIN55,212-2 INDUCES APOPTOSIS IN HUMAN HEPATOMA CELLS. 77
SAHA induces acetylation of p53 and histones in human hepatoma HepG2 cells 71
Totale 8.702
Categoria #
all - tutte 29.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021473 0 0 0 0 0 36 72 38 84 72 89 82
2021/2022643 39 156 13 18 10 15 20 22 98 98 24 130
2022/2023885 107 113 18 110 97 153 65 66 96 2 48 10
2023/2024397 20 65 24 47 31 85 25 34 6 3 9 48
2024/20251.004 20 86 59 70 42 55 53 50 51 99 160 259
2025/20261.477 280 143 251 240 377 186 0 0 0 0 0 0
Totale 8.702